LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.
Clinical trial NCT07202897 · RECRUITING
Trial details
- NCT number
- NCT07202897
- Sponsor
- Rennes University Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-07
- Primary completion
- 2032-01-07
- Enrollment
- 532
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.